When was Avelo founded?

Avelo was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Where is Avelo located?

Avelo is headquartered in Schlieren, Switzerland. It is registered at Rütistrasse 16, 8952 Schlieren, CH.

How many employees does Avelo have?

As of May 31, 2026, the latest employee count at Avelo is 8.

Is Avelo a funded company?

Avelo is a funded company, having raised a total of $2.28M across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 22, 2022.

When was the latest funding round of Avelo?

Avelo's latest funding was a $***** Seed round on Sep 20, 2022, with participation from 4 investors. Its primary sector is Infectious Diseases. In Switzerland, the Infectious Diseases sector has seen $19.3M in funding in 2026 to date.

Where does Avelo rank among its competitors?

Avelo ranks 9th amongst 39 active competitors, of which 12 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Nuclein, which secured $19.1M in Jul, 2025.

Who are the top competitors of Avelo?

Avelo's top competitors include Lifeloc, Nuclein and Apieron. Among them, Nuclein secured the most recent funding round in July, 2025.

Avelo - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of a breath aerosol diagnostic device for respiratory infections. It offers a device for a non-invasive breath test that detects multiple lower respiratory tract infections such as TB, Influenza, RSV, and Coronaviruses.

Website: www.avelolife.com/
Email ID: *****@avelolife.com
Phone Number: +41 **********
Registered Address: Rütistrasse 16, 8952 Schlieren, CH

Key Metrics

Founded Year

2020

Location

Schlieren, Switzerland

Stage

Seed

Total Funding

$2.28M in 2 rounds

Latest Funding Round

Seed, Sep 20, 2022, $*****

Investors

OCCIDENT & 5 more

Ranked

9^th among 39 active competitors

Employee Count

8 as on May 31, 2026

Similar Companies

Lifeloc & 52 more

View Avelo's full profile

Avelo is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Avelo AG CIN: 1456812 , Switzerland, Active	Jun 19, 2023	-	-	-

Avelo has raised a total funding of $2.28M over 2 rounds. Its first funding round was on Jun 22, 2022. Its latest funding round was a Seed round on Sep 20, 2022 for $*****. 4 investors participated in its latest round. Avelo has 6 institutional investors.

Here is the list of recent funding rounds of Avelo:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 20, 2022	4680237	Seed	4133948	5847910	7996967	9572026
Jun 22, 2022	1894733	Grant (prize money)	2643458	5260779	9493033	Venture Kick

Access funding benchmarks and valuations. Sign up today!

View details of Avelo's funding rounds and investors

The founders of Avelo is Tobias Broger.

Here are the details of Avelo's key team members:

Tobias Broger: Co-Founder of Avelo.

View details of Avelo's Founder profiles and Board Members

Avelo's employee count trend

Avelo has 8 employees as of May 26. Here is Avelo's employee count trend over the years:

Uncover Avelo's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Avelo include Lifeloc, Nuclein and Apieron. Here is the list of Top 10 competitors of Avelo, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Lifeloc 1983, Denver (United States), Funding Raised	Breath alcohol and drug testing solutions for safety and compliance	-	Colorado Office of Economic Development and International Trade ... Read more	48/100
2nd	Nuclein 2017, Austin (United States), Series B	Developer of handheld PCR device for the detection of infectious disease	$20M	Trinity Investors	41/100
3rd	Apieron 2001, Menlo Park (United States), Deadpooled	Asthma monitoring device	$68.5M	Alliance Venture, DFJ & 3 others	39/100
4th	Heroic-Faith 2018, Taipei (Taiwan), Series A	Provider of AI-based device for lung disease diagnosis	$19.6M	Integral Group, Y Combinator & 8 others	39/100
5th	CellScope 2010, San Francisco (United States), Series A	In-ear visibility using mobile device for at-home diagnosis	$4.62M	Khosla Ventures, Rock Health & 1 others	39/100
6th	Deversify 2016, Uppsala (Sweden), Seed	Developer of breath analyzers for measuring acetone concentration	-	Katapult, Aggregate Media & 1 others	37/100
7th	Linshom 2009, Ellicott City (United States), Series A	Developer of respiratory monitoring devices	$3.35M	TEDCO, Abell Foundation & 4 others	36/100
8th	Eversens 2015, Pamplona (Spain), Seed	Developer of non-invasive diagnostic system to detect bio-markers	-	Europa, NIH & 6 others	35/100
9th	Avelo 2020, Schlieren (Switzerland), Seed	Developer of a breath aerosol diagnostic device for respiratory infections	$2.28M	Zurcher Kantonalbank, OCCIDENT & 4 others	35/100
10th	Medipines 2014, Yorba Linda (United States), Seed	Innovating cardiorespiratory assessment with non-invasive, point-of-care technology	$2.56M	-	34/100